One that spent $26m on interest bill
has NET payables of another $28m
all in just a quarter!!!.....before even doing a thing.....POOOoooOOOOFFF up in smoke
That's what doing FDA trials looks like. ACTUALLY doing multiple trials.
Talking about doing trials is what you have here.
Not doing = no demand for shares, regardless of price offered.
Given the recent last CR, MSB could do another CR for around the same and perhaps a touch more. Not ideal but I'm confident it could be done.
CYP has a 'hail Mary' that someone saves them.
This company is going to pay dearly for the MEND trial. Credibility is lost at a critical stage.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.015(9.68%) |
Mkt cap ! $38.41M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 17.0¢ | 15.5¢ | $47.10K | 289.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 23813 | 3 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |